Volume 6, Issue 1 (2020)                   Pharm Biomed Res 2020, 6(1): 37-49 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Amaldoss M J N. Fabrication and characterisation of lavender oil - plant phospholipid based Sumatriptan succinate hybrid solid lipid nanoparticles.. Pharm Biomed Res. 2020; 6 (1) :37-49
URL: http://pbr.mazums.ac.ir/article-1-278-en.html
School of Materials Science and Engineering, UNSW Sydney, NSW, Australia
Abstract:   (286 Views)
Background:  Nanostructured lipid carriers (NLCs) of sumatriptan succinate (SS) were prepared by using lavender oil.  In ancient days, lavender oil was used for the treatment of a migraine. The natural anti-migraine agent, lavender oil, combined with an anti-migraine drug such as SS in a nano-formulation, will be a practical alternative approach in migraine therapy. 
Objective: NLCs of sumatriptan succinate were fabricated by using a natural anti-migraine oil (lavender oil), LECIVA-S70, which is a specialized grade for liposomal dermatological preparation and designed for emulsion, fat infusions, nutraceutical formulations, and parenteral use. It contains 70% phosphatidylcholine, which is not generally present in the regular soy lecithin.
Methods: The central composite design technique was used to examine the relationship between independent variables and responses such as lavender oil and LECIVA-S70. The dependent variables were Z-average (R1), polydispersity index (R2), and % entrapment efficiency (R3).  The NLCs were prepared with the double emulsification technique.  The Fourier transform infrared spectroscopy, X-ray diffraction, and differential scanning calorimetry analyzed the drug excipient compatibility profile. The developed NLCs were characterized for particle size by using Mastersizer, Zetasizer, and transmission electron microscopy.  The membrane diffusion technique studied the in vitro drug release profile.
Results: The mean±SD size of the NLCs ranged from 411.4±311.1 d.nm to 398.8±242.6 d.nm. The best formulation (SNE9) demonstrated an average diameter of 398.8±242.6 d.nm, with the PDI of 0.216, and zeta potential of 17.18 mV.
Conclusion: The optimized formula demonstrated the narrow size range, a satisfactory zeta potential, high drug loading, and reproducible drug release profile. The NLCs successfully retained the aroma of the lavender oil. According to ANOVA, the polydispersity index (R2) is significant with the central composite design.
     
Type of Study: Research | Subject: Nanotechnology

Add your comments about this article : Your username or Email:
CAPTCHA

© 2020 All Rights Reserved | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb